Clinical Trial Update: Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 relative bioavailability study of a pediatric granule formulation of dolutegravir. The trial, conducted by ViiV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae | Phase 1 | Status: COMPLETED